share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Thornberry Nancy

SEC announcement ·  May 4 04:28
Summary by Futu AI
Nancy Thornberry, associated with Vertex Pharmaceuticals Inc. [VRTX], completed a transaction on May 1, 2024, acquiring 501 shares of common stock at no cost. This grant transaction has increased Thornberry's direct holdings to a total of 1,637 shares in the company. The transaction, which was completed as a grant, award, or other acquisition, reflects a continued investment in the company by Thornberry.
Nancy Thornberry, associated with Vertex Pharmaceuticals Inc. [VRTX], completed a transaction on May 1, 2024, acquiring 501 shares of common stock at no cost. This grant transaction has increased Thornberry's direct holdings to a total of 1,637 shares in the company. The transaction, which was completed as a grant, award, or other acquisition, reflects a continued investment in the company by Thornberry.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.